Implementing KDOQI CKD Definition and Staging Guidelines in Southern California Kaiser Permanente Mark Rutkowski, MD, Wendy Mann, PharmD, Stephen Derose,

Slides:

Advertisements

Similar presentations

Commentary on ‘The DOPPS Practice Monitor for US Dialysis Care: Potential Impact of Recent Guidelines and Regulatory Changes on Management of Mineral.

Advertisements

Fredrik Karlsson, MD, Angelo Modica, MD, Thomas Mooe, MD, PhD

Renal Function Testing

KDOQI US Commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD Mark J. Sarnak, MD, MS, Roy Bloom, MD, Paul Muntner, PhD,

American Journal of Kidney Diseases

Estimating GFR Using the CKD Epidemiology Collaboration (CKD-EPI) Creatinine Equation: More Accurate GFR Estimates, Lower CKD Prevalence Estimates, and.

KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update

Olivier Niel, MD, PhD, Charlotte Boussard, MSc, Paul Bastard, MSc

Susan P.Y. Wong, MD, Ann M. O'Hare, MD, MA

Core Assessment of Predonation Kidney Function: Clarification of the 2017 KDIGO Living Donor Guideline Krista L. Lentine, MD, PhD, Andrew S. Levey, MD,

Metabolic Complications in Elderly Adults With CKD

Development of Reduced Kidney Function in Rheumatoid Arthritis

Jessica W. Weiss, MD, Eric S. Johnson, PhD, Amanda Petrik, MS, David H

Care of the Undocumented Immigrant in the United States With ESRD

Francesca Mallamaci, MD, Giovanni Tripepi, PhD

A Decade After the KDOQI CKD Guidelines

Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study Equations: Risk Factors for and Complications.

Sustainable Community-Based CKD Screening Methods Employed by the National Kidney Foundation's Kidney Early Evaluation Program (KEEP) Peter A. McCullough,

Kaiser Permanente Creatinine Safety Program: A Mechanism to Ensure Widespread Detection and Care for Chronic Kidney Disease John J. Sim, MD, Mark P.

Joseph A. Vassalotti, MD, Beth Piraino, MD, Lynda A. Szczech, MD

Cardiovascular Disease and CKD: Core Curriculum 2010

Matei Neagu, PhD, Daniel Coca, PhD, Albert C.M. Ong, DM

Chronic Kidney Disease in Diabetes

Risk Factors for ESRD in Individuals With Preserved Estimated GFR With and Without Albuminuria: Results From the Kidney Early Evaluation Program (KEEP)

Evaluating the Contribution of the Cause of Kidney Disease to Prognosis in CKD: Results From the Study of Heart and Renal Protection (SHARP) Richard.

A New Clinical Prediction Tool for 5-Year Kidney Transplant Outcome

Susumu Takahashi, Kazuyoshi Okada, Mitsuru Yanai Kidney International

Advances in CKD Detection and Determination of Prognosis: Executive Summary of the National Kidney Foundation–Kidney Early Evaluation Program (KEEP) 2012.

I. Introduction American Journal of Kidney Diseases

Focusing on Health Literacy Might Help Us Cross the Quality Chasm

Daniel E. Weiner, MD, MS American Journal of Kidney Diseases

National Kidney Foundation American Journal of Kidney Diseases

Glycemic Management in ESRD and Earlier Stages of CKD

Guidelines for the Older Adult With CKD

Lifetime Incidence of CKD Stages 3-5 in the United States

The Kidney Early Evaluation Program (KEEP): Program Design and Demographic Characteristics of the Population Claudine T. Jurkovitz, MD, MPH, Yang Qiu,

Navdeep Tangri, MD, FRCPC, Daniel E. Weiner, MD, MS

A Decade After the KDOQI CKD Guidelines: A Historical Perspective

CKD as an Underrecognized Threat to Patient Safety

Polyunsaturated Fatty Acids and Kidney Disease

A Decade After the KDOQI CKD Guidelines: A Perspective From Mexico

CPR 1.2.: Evaluation of Anemia in CKD

Nephrology: As It Was Then, But Is Not Now

Plasma Parathyroid Hormone Level and Prevalent Cardiovascular Disease in CKD Stages 3 and 4: An Analysis From the Kidney Early Evaluation Program (KEEP)

Beef Tea, Vitality, Creatinine, and the Estimated GFR

American Journal of Kidney Diseases

Evidence and Outcomes in CKD

Drug Dose Adjustments in Patients With Renal Impairment

Daniel E. Weiner, MD, MS, Mark J. Sarnak, MD, MS

Methods for guideline development

Risk for Incident Renal Dialysis in a Managed Care Population

Michael J. Germain, MD, Sara N. Davison, MD, Alvin H. Moss, MD

Long-term Outcomes of Acute Kidney Injury: The Power and Pitfalls of Observational/Population-Based Studies Charuhas V. Thakar, MD American Journal.

Arjang Djamali, Christina Kendziorski, Peter C. Brazy, Bryan N. Becker

Removal of Dabigatran by Hemodialysis

Multidrug-Resistant Organisms Within the Dialysis Population: A Potentially Preventable Perfect Storm David P. Calfee, MD, MS American Journal of Kidney.

Volume 76, Issue 6, Pages (September 2009)

National Kidney Foundation's Kidney Early Evaluation Program (KEEP) Annual Data Report 2011: Executive Summary Adam T. Whaley-Connell, DO, MSPH, Joseph.

Hypertension and CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES), Madhav V. Rao,

Achieving Fairness in Access to Kidney Transplant: A Work in Progress

Commentary on ‘The DOPPS Practice Monitor for US Dialysis Care: Potential Impact of Recent Guidelines and Regulatory Changes on Management of Mineral.

James F. Winchester, MD, Thomas H. Hostetter, MD, Timothy W. Meyer, MD

Patient Safety Issues in CKD: Core Curriculum 2015

Supportive care for patients with renal disease: Time for action

Jordi Goldstein-Fuchs, DSc, RD, RN, Denis Fouque, MD, PhD

Ann M. O'Hare, MA, MD American Journal of Kidney Diseases

Clinical Practice Recommendations For Peritoneal Dialysis Adequacy

National Kidney Foundation's Kidney Early Evaluation Program (KEEP) Annual Data Report 2009: Executive Summary Peter A. McCullough, MD, MPH, Joseph A.

A Decade After the KDOQI CKD Guidelines: Impact on the National Kidney Foundation's Kidney Early Evaluation Program (KEEP) Adam Whaley-Connell, DO, MSPH

Clinical Practice Guidelines for Peritoneal Dialysis Adequacy

Presentation transcript:

Implementing KDOQI CKD Definition and Staging Guidelines in Southern California Kaiser Permanente Mark Rutkowski, MD, Wendy Mann, PharmD, Stephen Derose, MD, MS, David Selevan, BS, Noel Pascual, HS, Jean Diesto, RN, BSN, Peter Crooks, MD American Journal of Kidney Diseases Volume 53, Issue 3, Pages S86-S99 (March 2009) DOI: 10.1053/j.ajkd.2008.07.052 Copyright © 2009 National Kidney Foundation, Inc. Terms and Conditions

Figure 1 Care management summary sheet with examples of recommedations that could be shown for particular patients. Abbreviations: CKD, chronic kidney disease; CV, cardiovascular disease; DM, diabetes mellitus; eGFR, estimated glomerular filtration rate; ESRD, end-stage renal disease; LDL, low-density lipoprotein; SCKP, Southern California Kaiser Permanente. American Journal of Kidney Diseases 2009 53, S86-S99DOI: (10.1053/j.ajkd.2008.07.052) Copyright © 2009 National Kidney Foundation, Inc. Terms and Conditions